NYSE · CIK 0001756655
ARDT Ardent Health, Inc.
Insider trading from SEC Form 4. Last filing 13 d ago. Close $11.30 on Oct 9, 2026, +44% from the 52-week low and -26% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
ARDTOct 9, 2026 · close 11.30
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Ardent Health, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Robert Thomas Webb director buy | $340k 20,000 shares | +99% | - |
Transactions
The last 38 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Stephen C. Petrovich EVP, GC and Secretary | FTax withholding Common Stock | -788 | $10.54 | $8,306 | 773,919 | 13 d ago |
| Sep 25, 2026 | Alfred Lumsdaine Chief Financial Officer | FTax withholding Common Stock | -3,389 | $10.54 | $36k | 325,794 | 13 d ago |
| Sep 25, 2026 | David Raynor Byers SVP & Chief Accounting Officer | FTax withholding Common Stock | -524 | $10.54 | $5,523 | 129,921 | 13 d ago |
| Sep 25, 2025 | David Raynor Byers SVP & Chief Accounting Officer | FTax withholding Common Stock | -524 | $13.19 | $6,912 | 111,791 | Sep 30, 2025 |
| Sep 25, 2025 | Stephen C. Petrovich EVP, GC and Asst. Secretary | FTax withholding Common Stock | -788 | $13.19 | $10k | 718,303 | Sep 30, 2025 |
| Sep 25, 2025 | Alfred Lumsdaine Chief Financial Officer | FTax withholding Common Stock | -3,389 | $13.19 | $45k | 211,147 | Sep 30, 2025 |
| Apr 2, 2025 | Robert DeMichiei director | AGrant or award Common Stock | +10,073 | $0.00 | $0 | 10,073 | Apr 4, 2025 |
| Mar 31, 2025 | David Schultz President Hospital Operations | FTax withholding Common Stock | -1,825 | $13.75 | $25k | 37,187 | Apr 2, 2025 |
| Mar 31, 2025 | David Raynor Byers SVP & Chief Accounting Officer | FTax withholding Common Stock | -676 | $13.75 | $9,295 | 100,750 | Apr 2, 2025 |
| Mar 31, 2025 | Ethan Chernin President of Health Services | FTax withholding Common Stock | -1,332 | $13.75 | $18k | 15,074 | Apr 2, 2025 |
| Mar 31, 2025 | Stephen C. Petrovich EVP, GC and Asst. Secretary | FTax withholding Common Stock | -1,428 | $13.75 | $20k | 696,828 | Apr 2, 2025 |
| Mar 31, 2025 | Alfred Lumsdaine Chief Financial Officer | FTax withholding Common Stock | -2,510 | $13.75 | $35k | 160,565 | Apr 2, 2025 |
| Mar 31, 2025 | Martin Bonick President and CEO | FTax withholding Common Stock | -12,970 | $13.75 | $178k | 992,057 | Apr 2, 2025 |
| Apr 1, 2025 | Dave Caspers Chief Operating Officer | AGrant or award Common Stock | +7,711 | $0.00 | $0 | 7,711 | Apr 2, 2025 |
| Apr 1, 2025 | Dave Caspers Chief Operating Officer | FTax withholding Common Stock | -2,480 | $12.97 | $32k | 5,231 | Apr 2, 2025 |
| Apr 1, 2025 | David Raynor Byers SVP & Chief Accounting Officer | AGrant or award Common Stock | +11,565 | $0.00 | $0 | 112,315 | Apr 2, 2025 |
| Apr 1, 2025 | Ethan Chernin President of Health Services | AGrant or award Common Stock | +20,914 | $0.00 | $0 | 35,988 | Apr 2, 2025 |
| Apr 1, 2025 | David Schultz President Hospital Operations | AGrant or award Common Stock | +26,985 | $0.00 | $0 | 64,172 | Apr 2, 2025 |
| Apr 1, 2025 | Stephen C. Petrovich EVP, GC and Asst. Secretary | AGrant or award Common Stock | +22,263 | $0.00 | $0 | 719,091 | Apr 2, 2025 |
| Apr 1, 2025 | Alfred Lumsdaine Chief Financial Officer | AGrant or award Common Stock | +53,971 | $0.00 | $0 | 214,536 | Apr 2, 2025 |
| Apr 1, 2025 | Martin Bonick President and CEO | AGrant or award Common Stock | +134,927 | $0.00 | $0 | 1,126,984 | Apr 2, 2025 |
| Apr 1, 2025 | Dave Caspers Chief Operating Officer | AGrant or award Common Stock | +33,057 | $0.00 | $0 | 38,288 | Apr 2, 2025 |
| Mar 21, 2025 | Rahul Sen director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 24,478 | Mar 25, 2025 |
| Mar 21, 2025 | Suzanne Campion director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 43,984 | Mar 25, 2025 |
| Mar 21, 2025 | Peter C B Bynoe director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 101,136 | Mar 25, 2025 |
| Mar 21, 2025 | William M Goodyear director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 101,136 | Mar 25, 2025 |
| Mar 21, 2025 | Ellen Havdala director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 101,136 | Mar 25, 2025 |
| Mar 21, 2025 | Mark R Sotir director, other | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 24,478 | Mar 25, 2025 |
| Mar 21, 2025 | Edmondo Robinson director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 43,984 | Mar 25, 2025 |
| Mar 21, 2025 | Robert Thomas Webb director | AGrant or award Common Stock | +12,916 | $0.00 | $0 | 63,984 | Mar 25, 2025 |
| Dec 12, 2024 | William M Goodyear director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 88,220 | Dec 16, 2024 |
| Dec 12, 2024 | Suzanne Campion director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 31,068 | Dec 16, 2024 |
| Dec 12, 2024 | Peter C B Bynoe director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 88,220 | Dec 16, 2024 |
| Dec 12, 2024 | Ellen Havdala director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 88,220 | Dec 16, 2024 |
| Dec 12, 2024 | Edmondo Robinson director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 31,068 | Dec 16, 2024 |
| Dec 12, 2024 | Robert Thomas Webb director | AGrant or award Common Stock | +10,793 | $0.00 | $0 | 51,068 | Dec 16, 2024 |
| Nov 8, 2024 | Robert Thomas Webb director | POpen-market purchase Common Stock | +10,000 | $17.47 | $175k | 30,275 | Nov 13, 2024 |
| Nov 8, 2024 | Robert Thomas Webb director | POpen-market purchase Common Stock | +10,000 | $16.49 | $165k | 40,275 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Peter C B Bynoedirector
- Martin BonickPresident and CEO
- David Raynor ByersSVP & Chief Accounting Officer
- Suzanne Campiondirector
- Dave CaspersChief Operating Officer
- Ethan CherninPresident of Health Services
- Robert DeMichieidirector
- William M Goodyeardirector
- Ellen Havdaladirector
- Alfred LumsdaineChief Financial Officer
- Stephen C. PetrovichEVP, GC and Asst. Secretary
- Edmondo Robinsondirector
- David SchultzPresident Hospital Operations
- Rahul Sendirector
- Mark R Sotirdirector, other
- Robert Thomas Webbdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.